Matsusaka, S; Wu, A H; Cao, S; Hanna, D L; Chin, K; Yang, D; Zhang-Wu, Xiaxia; Ning, Y; Stintzing, S; Sebio, A; Sunakawa, Y; Stremitzer, S; Yamauchi, S; Okazaki, S; Berger, Martin Dave; Parekh, A; Miyamoto, Y; Mizunuma, N; Lenz, H-J (2018). Prognostic impact of FOXF1 polymorphisms in gastric cancer patients. Pharmacogenomics journal, 18(2), pp. 262-269. Nature Publishing Group 10.1038/tpj.2017.9
Text
unbekannt 5.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (192kB) |
A recent genome-wide association study identified seven single-nucleotide polymorphisms (SNPs) in region 16q24, near the Forkhead box-F1 (FOXF1) gene, which confer susceptibility to esophageal adenocarcinoma. We examined whether these SNPs are associated with clinical outcomes in gastric cancer (GC) patients in Japan and the United States. A total of 362 patients were included in this study: 151 Japanese GC patients treated with first-line S1 plus CDDP (training cohort) and 211 GC patients from Los Angeles County (LAC; validation cohort). Genomic DNA was isolated from whole blood or tumor tissue and analyzed by PCR-based direct DNA sequencing. Cox proportional hazard regression analyses were used to assess relationships between FOXF1 SNPs and progression-free survival (PFS) and overall survival (OS). FOXF1 rs3950627 was significantly associated with survival in both the training and validation cohorts. Japanese patients with the C/C genotype had a longer PFS (median 8.2 vs 5.3 months, hazard ratio (HR) 1.44, P=0.037) and OS (median 16.4 vs 12.2 months, HR 1.44, P=0.043) compared to patients with any A allele. Similarly, LAC patients with the C/C genotype had improved OS (3.9 vs 2.3 years, HR 1.5, P=0.022). Subgroup analyses showed these associations were specific to male patients and primary tumor subsite. Our findings suggest that FOXF1 rs3950627 might be a promising prognostic marker in GC patients.The Pharmacogenomics Journal advance online publication, 11 April 2017; doi:10.1038/tpj.2017.9.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Translational Research Center 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Berger, Martin Dave |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1470-269X |
Publisher: |
Nature Publishing Group |
Language: |
English |
Submitter: |
Nicole Corminboeuf |
Date Deposited: |
07 Mar 2018 18:33 |
Last Modified: |
05 Dec 2022 15:10 |
Publisher DOI: |
10.1038/tpj.2017.9 |
PubMed ID: |
28398355 |
BORIS DOI: |
10.7892/boris.111406 |
URI: |
https://boris.unibe.ch/id/eprint/111406 |